Article
Immunogenicity and Safety of an F-Genotype Attenuated Mumps Vaccine in Healthy 8- to 24-Month-Old Children.
The Journal of infectious diseases - 1 Jan 2019
Liang Yan, Che Yanchun, Yang Beifang, Zhan Faxian, Li Hong, Guan Xuhua, Zhang Ying, Yin Qiongzhou, Li Changgui, Li Jing, Zhao Zhimei, Liu Longding, Jiang Guorun, Liao Yun, Xu Xingli, Ye Jianjun, Ren Qunhui, He Yonghua, Feng Min, Wang Lichun, Fan Shengtao, Cui Xiaoyu, Wang Zhao, Li Chuanyin, Xiao Haitao, Liu Rong, Li Qiong, Jiang Changjun, Liu Jianqun, Li Qihan
Abstract excerpt
Background: Mumps vaccine immunizations have reduced the incidence of this disease. With the variation of mumps circulating strain, novel vaccine strains are always important. Methods: A 2-center parallel, randomized, double-blind noninferiority trial was performed to compare an F-genotype attenuated mumps vaccine (SP strain) to the A-genotype vaccine (S-79, Jeryl-Lynn strain) in 1080 healthy children aged 8-24...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.